SpyGlass Pharma Q3 Loss Widens
(RTTNews) - SpyGlass Pharma, Inc. (SGP), a late-stage biopharmaceutical company focused on chronic eye conditions, reported wider third-quarter losses
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.